RPS19P3

Across TCGA pan-cancer cohorts, RPS19P3 RNA is linked to patient survival in 25 of 34 cancer types, making it the most broadly survival-associated RPS19P3 data layer.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher RPS19P3 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RPS19P3 expression acts as an unfavorable survival marker, although some lineages such as HNSC and BRCA show a favorable association.

ACC, KICH, and HNSC are the cancer types where RPS19P3 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ACC	DFS	Median	All	0.492	0.818	<.001	114	view →
KICH	OS	Median	III,IV	0.468	1.000	.001	45	view →
HNSC	OS	Tertile	II,III,IV	0.614	0.358	.004	35	view →
LGG	OS	Tertile	All	0.280	0.588	<.001	27	view →
BRCA	OS	Median	III,IV	0.895	0.762	.001	25	view →
KIRC	DFS	Median	All	0.567	0.684	.001	24	view →
STAD	OS	Median	III,IV	0.530	0.722	.005	21	view →
LIHC	DFS	Median	All	0.483	0.598	.011	17	view →
LUSC	DFS	Tertile	II,III,IV	0.490	0.838	.007	12	view →
KIRP	DFS	Tertile	All	0.681	0.821	.010	11	view →
DLBC	DFS	Quartile	III,IV	0.167	1.000	.010	11	view →
GBM	DFS	Tertile	All	0.357	0.204	.042	11	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 25 lineages.

RPS19P3–ACC (DFS)

Open the ACC breakdown →